Skip to main content

Table 1 Summary of histopathological evaluation of lung tissue of rats exposed to DQ12, DQ-PVNO or PBS

From: Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs

Alveolar lipoproteinosis

Mixed cell alveolar inflammation

 

PBS

DQ12

DQ12-PVNO

 

PBS

DQ12

DQ12-PVNO

3d

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

3d

0.0 ± 0.0

1.2 ± 0.7*

0.0 ± 0.0#

7d

0.0 ± 0.0

0.2 ± 0.4

0.0 ± 0.0

7d

0.0 ± 0.0

1.1 ± 0.7*

0.5 ± 0.6

28d

0.0 ± 0.0

1.0 ± 0.3**

0.3 ± 0.4##

28d

0.0 ± 0.0

0.8 ± 1.1

0.0 ± 0.0

90d

0.0 ± 0.0

1.3 ± 0.8*

0.0 ± 0.0#

90d

0.0 ± 0.0

0.5 ± 0.4

0.1 ± 0.2

180d

0.0 ± 0.0

2.0 ± 0.4**

0.3 ± 0.4##

180d

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

360d

0.0 ± 0.0

2.6 ± 1.5**

2.9 ± 1.5$$

360d

0.0 ± 0.0

0.6 ± 1.0

0.0 ± 0.0

Alveolar histocytosis

Brochoalveolar hyperplasia

 

PBS

DQ12

DQ12-PVNO

 

PBS

DQ12

DQ12-PVNO

3d

0.0 ± 0.0

0.8 ± 0.7

0.1 ± 0.3

3d

0.0 ± 0.0

0.7 ± 0.9

0.3 ± 0.7

7d

0.3 ± 0.7

1.5 ± 0.7

0.5 ± 0.4#

7d

0.9 ± 1.8

2.2 ± 1.4

0.6 ± 0.8

28d

1.0 ± 0.4

3.4 ± 1.4*

1.4 ± 0.8#

28d

1.0 ± 0.4

3.1 ± 1.8

1.4 ± 1.2

90d

0.4 ± 0.7

3.8 ± 0.6**

1.0 ± 0.7##

90d

0.8 ± 1.0

2.6 ± 1.4

0.6 ± 0.3

180d

0.8 ± 0.4

2.4 ± 0.6*

2.5 ± 1.0 $

180d

0.1 ± 0.3

2.3 ± 1.0**

2.3 ± 0.7 $$

360d

0.3 ± 0.3

3.0 ± 0.6**

2.0 ± 0.4 $$,#

360d

0.0 ± 0.0

5.5 ± 1.1**

3.9 ± 1.0 $$,#

Fibrosis alveolar septa

Perivascular fibrosis

 

PBS

DQ12

DQ12-PVNO

 

PBS

DQ12

DQ12-PVNO

3d

0.0 ± 0.0

0.1 ± 0.3

0.0 ± 0.0

3d

1.0 ± 0.2

1.0 ± 0.0

0.9 ± 0.2

7d

0.0 ± 0.0

0.0 ± 0.0

0.0 ± 0.0

7d

0.6 ± 0.2

1.0 ± 0.0*

1.0 ± 0.0

28d

0.0 ± 0.0

0.4 ± 0.6

0.0 ± 0.0

28d

1.1 ± 0.2

1.3 ± 0.4

1.1 ± 0.2

90d

0.0 ± 0.0

1.0 ± 0.8*

0.0 ± 0.0#

90d

1.0 ± 0.0

1.4 ± 0.4

1.0 ± 0.0

180d

0.2 ± 0.2

1.4 ± 1.3

0.4 ± 0.4

180d

0.8 ± 0.2

1.6 ± 0.2**

1.5 ± 0.4 $

360d

0.7 ± 0.5

2.1 ± 0.2**

1.3 ± 0.5#

360d

1.1 ± 0.4

2.3 ± 0.2**

1.9 ± 0.4 $

  1. Histopathological evaluation of 2 lung lobes (left, right cranial) each stained with H&E and Sirius red 3, 7, 28, 90, 180 and 360 days after one single intratracheal instillation of PBS, DQ12 or DQ12-PVNO. For histopathological scoring, data were calculated as the sum of lesion severity and distribution. The mean of the two lobes was calculated and data expressed as mean ± sd of 5 animals per treatment and time point. DQ12 vs. PBS: * p <0.05; ** p <0.01; DQ12-PVNO vs. PBS: $ p < 0.05, $$ p > 0.01; DQ12 vs. DQ12-PVNO: # p <0.05; ## p <0.01.